Global Neoantigen Targeted Therapy Market Growth (Status and Outlook) 2026-2032
The global Neoantigen Targeted Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
LPI (LP Information)' newest research report, the “Neoantigen Targeted Therapy Industry Forecast” looks at past sales and reviews total world Neoantigen Targeted Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Neoantigen Targeted Therapy sales for 2026 through 2032. With Neoantigen Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neoantigen Targeted Therapy industry.
This Insight Report provides a comprehensive analysis of the global Neoantigen Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neoantigen Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neoantigen Targeted Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neoantigen Targeted Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neoantigen Targeted Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Neoantigen Targeted Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
LPI (LP Information)' newest research report, the “Neoantigen Targeted Therapy Industry Forecast” looks at past sales and reviews total world Neoantigen Targeted Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Neoantigen Targeted Therapy sales for 2026 through 2032. With Neoantigen Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neoantigen Targeted Therapy industry.
This Insight Report provides a comprehensive analysis of the global Neoantigen Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neoantigen Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neoantigen Targeted Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neoantigen Targeted Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neoantigen Targeted Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Neoantigen Targeted Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Off-the-shelf Neoantigen
- Personalized Neoantigen
- Colorectal Cancer
- Renal Cell Carcinoma
- Non-Small Cell Lung cancer
- Bone Cancer
- Gynecological Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BioNTech SE
- Gritstone Bio
- Genocea Biosciences
- Moderna
- Agenus
- Immatics
- Advaxis
- Precision Biologics
- Gilead Sciences
- Cellular Biomedicine Group
- Achilles Therapeutics
- Merck and Co
- Beijing Kati Medical Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neoantigen Targeted Therapy Market Size (2021-2032)
2.1.2 Neoantigen Targeted Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neoantigen Targeted Therapy by Country/Region (2021, 2025 & 2032)
2.2 Neoantigen Targeted Therapy Segment by Type
2.2.1 Off-the-shelf Neoantigen
2.2.2 Personalized Neoantigen
2.2.3 Neoantigen Targeted Therapy Market Size by Type
2.2.3.1 Neoantigen Targeted Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
2.3 Neoantigen Targeted Therapy Segment by Application
2.3.1 Colorectal Cancer
2.3.2 Renal Cell Carcinoma
2.3.3 Non-Small Cell Lung cancer
2.3.4 Bone Cancer
2.3.5 Gynecological Cancer
2.3.6 Others
2.3.7 Neoantigen Targeted Therapy Market Size by Application
2.3.7.1 Neoantigen Targeted Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
3 NEOANTIGEN TARGETED THERAPY MARKET SIZE BY PLAYER
3.1 Neoantigen Targeted Therapy Market Size Market Share by Player
3.1.1 Global Neoantigen Targeted Therapy Revenue by Player (2021-2026)
3.1.2 Global Neoantigen Targeted Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Neoantigen Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEOANTIGEN TARGETED THERAPY BY REGION
4.1 Neoantigen Targeted Therapy Market Size by Region (2021-2026)
4.2 Global Neoantigen Targeted Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neoantigen Targeted Therapy Market Size Growth (2021-2026)
4.4 APAC Neoantigen Targeted Therapy Market Size Growth (2021-2026)
4.5 Europe Neoantigen Targeted Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Neoantigen Targeted Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neoantigen Targeted Therapy Market Size by Country (2021-2026)
5.2 Americas Neoantigen Targeted Therapy Market Size by Type (2021-2026)
5.3 Americas Neoantigen Targeted Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neoantigen Targeted Therapy Market Size by Region (2021-2026)
6.2 APAC Neoantigen Targeted Therapy Market Size by Type (2021-2026)
6.3 APAC Neoantigen Targeted Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neoantigen Targeted Therapy Market Size by Country (2021-2026)
7.2 Europe Neoantigen Targeted Therapy Market Size by Type (2021-2026)
7.3 Europe Neoantigen Targeted Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neoantigen Targeted Therapy by Region (2021-2026)
8.2 Middle East & Africa Neoantigen Targeted Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Neoantigen Targeted Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEOANTIGEN TARGETED THERAPY MARKET FORECAST
10.1 Global Neoantigen Targeted Therapy Forecast by Region (2027-2032)
10.1.1 Global Neoantigen Targeted Therapy Forecast by Region (2027-2032)
10.1.2 Americas Neoantigen Targeted Therapy Forecast
10.1.3 APAC Neoantigen Targeted Therapy Forecast
10.1.4 Europe Neoantigen Targeted Therapy Forecast
10.1.5 Middle East & Africa Neoantigen Targeted Therapy Forecast
10.2 Americas Neoantigen Targeted Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Neoantigen Targeted Therapy Forecast
10.2.2 Canada Market Neoantigen Targeted Therapy Forecast
10.2.3 Mexico Market Neoantigen Targeted Therapy Forecast
10.2.4 Brazil Market Neoantigen Targeted Therapy Forecast
10.3 APAC Neoantigen Targeted Therapy Forecast by Region (2027-2032)
10.3.1 China Neoantigen Targeted Therapy Market Forecast
10.3.2 Japan Market Neoantigen Targeted Therapy Forecast
10.3.3 Korea Market Neoantigen Targeted Therapy Forecast
10.3.4 Southeast Asia Market Neoantigen Targeted Therapy Forecast
10.3.5 India Market Neoantigen Targeted Therapy Forecast
10.3.6 Australia Market Neoantigen Targeted Therapy Forecast
10.4 Europe Neoantigen Targeted Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Neoantigen Targeted Therapy Forecast
10.4.2 France Market Neoantigen Targeted Therapy Forecast
10.4.3 UK Market Neoantigen Targeted Therapy Forecast
10.4.4 Italy Market Neoantigen Targeted Therapy Forecast
10.4.5 Russia Market Neoantigen Targeted Therapy Forecast
10.5 Middle East & Africa Neoantigen Targeted Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Neoantigen Targeted Therapy Forecast
10.5.2 South Africa Market Neoantigen Targeted Therapy Forecast
10.5.3 Israel Market Neoantigen Targeted Therapy Forecast
10.5.4 Turkey Market Neoantigen Targeted Therapy Forecast
10.6 Global Neoantigen Targeted Therapy Forecast by Type (2027-2032)
10.7 Global Neoantigen Targeted Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neoantigen Targeted Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 BioNTech SE
11.1.1 BioNTech SE Company Information
11.1.2 BioNTech SE Neoantigen Targeted Therapy Product Offered
11.1.3 BioNTech SE Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BioNTech SE Main Business Overview
11.1.5 BioNTech SE Latest Developments
11.2 Gritstone Bio
11.2.1 Gritstone Bio Company Information
11.2.2 Gritstone Bio Neoantigen Targeted Therapy Product Offered
11.2.3 Gritstone Bio Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gritstone Bio Main Business Overview
11.2.5 Gritstone Bio Latest Developments
11.3 Genocea Biosciences
11.3.1 Genocea Biosciences Company Information
11.3.2 Genocea Biosciences Neoantigen Targeted Therapy Product Offered
11.3.3 Genocea Biosciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Genocea Biosciences Main Business Overview
11.3.5 Genocea Biosciences Latest Developments
11.4 Moderna
11.4.1 Moderna Company Information
11.4.2 Moderna Neoantigen Targeted Therapy Product Offered
11.4.3 Moderna Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Moderna Main Business Overview
11.4.5 Moderna Latest Developments
11.5 Agenus
11.5.1 Agenus Company Information
11.5.2 Agenus Neoantigen Targeted Therapy Product Offered
11.5.3 Agenus Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Agenus Main Business Overview
11.5.5 Agenus Latest Developments
11.6 Immatics
11.6.1 Immatics Company Information
11.6.2 Immatics Neoantigen Targeted Therapy Product Offered
11.6.3 Immatics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Immatics Main Business Overview
11.6.5 Immatics Latest Developments
11.7 Advaxis
11.7.1 Advaxis Company Information
11.7.2 Advaxis Neoantigen Targeted Therapy Product Offered
11.7.3 Advaxis Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Advaxis Main Business Overview
11.7.5 Advaxis Latest Developments
11.8 Precision Biologics
11.8.1 Precision Biologics Company Information
11.8.2 Precision Biologics Neoantigen Targeted Therapy Product Offered
11.8.3 Precision Biologics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Precision Biologics Main Business Overview
11.8.5 Precision Biologics Latest Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Information
11.9.2 Gilead Sciences Neoantigen Targeted Therapy Product Offered
11.9.3 Gilead Sciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Gilead Sciences Main Business Overview
11.9.5 Gilead Sciences Latest Developments
11.10 Cellular Biomedicine Group
11.10.1 Cellular Biomedicine Group Company Information
11.10.2 Cellular Biomedicine Group Neoantigen Targeted Therapy Product Offered
11.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cellular Biomedicine Group Main Business Overview
11.10.5 Cellular Biomedicine Group Latest Developments
11.11 Achilles Therapeutics
11.11.1 Achilles Therapeutics Company Information
11.11.2 Achilles Therapeutics Neoantigen Targeted Therapy Product Offered
11.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Achilles Therapeutics Main Business Overview
11.11.5 Achilles Therapeutics Latest Developments
11.12 Merck and Co
11.12.1 Merck and Co Company Information
11.12.2 Merck and Co Neoantigen Targeted Therapy Product Offered
11.12.3 Merck and Co Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Merck and Co Main Business Overview
11.12.5 Merck and Co Latest Developments
11.13 Beijing Kati Medical Technology
11.13.1 Beijing Kati Medical Technology Company Information
11.13.2 Beijing Kati Medical Technology Neoantigen Targeted Therapy Product Offered
11.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Beijing Kati Medical Technology Main Business Overview
11.13.5 Beijing Kati Medical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neoantigen Targeted Therapy Market Size (2021-2032)
2.1.2 Neoantigen Targeted Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neoantigen Targeted Therapy by Country/Region (2021, 2025 & 2032)
2.2 Neoantigen Targeted Therapy Segment by Type
2.2.1 Off-the-shelf Neoantigen
2.2.2 Personalized Neoantigen
2.2.3 Neoantigen Targeted Therapy Market Size by Type
2.2.3.1 Neoantigen Targeted Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
2.3 Neoantigen Targeted Therapy Segment by Application
2.3.1 Colorectal Cancer
2.3.2 Renal Cell Carcinoma
2.3.3 Non-Small Cell Lung cancer
2.3.4 Bone Cancer
2.3.5 Gynecological Cancer
2.3.6 Others
2.3.7 Neoantigen Targeted Therapy Market Size by Application
2.3.7.1 Neoantigen Targeted Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
3 NEOANTIGEN TARGETED THERAPY MARKET SIZE BY PLAYER
3.1 Neoantigen Targeted Therapy Market Size Market Share by Player
3.1.1 Global Neoantigen Targeted Therapy Revenue by Player (2021-2026)
3.1.2 Global Neoantigen Targeted Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Neoantigen Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEOANTIGEN TARGETED THERAPY BY REGION
4.1 Neoantigen Targeted Therapy Market Size by Region (2021-2026)
4.2 Global Neoantigen Targeted Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neoantigen Targeted Therapy Market Size Growth (2021-2026)
4.4 APAC Neoantigen Targeted Therapy Market Size Growth (2021-2026)
4.5 Europe Neoantigen Targeted Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Neoantigen Targeted Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neoantigen Targeted Therapy Market Size by Country (2021-2026)
5.2 Americas Neoantigen Targeted Therapy Market Size by Type (2021-2026)
5.3 Americas Neoantigen Targeted Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neoantigen Targeted Therapy Market Size by Region (2021-2026)
6.2 APAC Neoantigen Targeted Therapy Market Size by Type (2021-2026)
6.3 APAC Neoantigen Targeted Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neoantigen Targeted Therapy Market Size by Country (2021-2026)
7.2 Europe Neoantigen Targeted Therapy Market Size by Type (2021-2026)
7.3 Europe Neoantigen Targeted Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neoantigen Targeted Therapy by Region (2021-2026)
8.2 Middle East & Africa Neoantigen Targeted Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Neoantigen Targeted Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEOANTIGEN TARGETED THERAPY MARKET FORECAST
10.1 Global Neoantigen Targeted Therapy Forecast by Region (2027-2032)
10.1.1 Global Neoantigen Targeted Therapy Forecast by Region (2027-2032)
10.1.2 Americas Neoantigen Targeted Therapy Forecast
10.1.3 APAC Neoantigen Targeted Therapy Forecast
10.1.4 Europe Neoantigen Targeted Therapy Forecast
10.1.5 Middle East & Africa Neoantigen Targeted Therapy Forecast
10.2 Americas Neoantigen Targeted Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Neoantigen Targeted Therapy Forecast
10.2.2 Canada Market Neoantigen Targeted Therapy Forecast
10.2.3 Mexico Market Neoantigen Targeted Therapy Forecast
10.2.4 Brazil Market Neoantigen Targeted Therapy Forecast
10.3 APAC Neoantigen Targeted Therapy Forecast by Region (2027-2032)
10.3.1 China Neoantigen Targeted Therapy Market Forecast
10.3.2 Japan Market Neoantigen Targeted Therapy Forecast
10.3.3 Korea Market Neoantigen Targeted Therapy Forecast
10.3.4 Southeast Asia Market Neoantigen Targeted Therapy Forecast
10.3.5 India Market Neoantigen Targeted Therapy Forecast
10.3.6 Australia Market Neoantigen Targeted Therapy Forecast
10.4 Europe Neoantigen Targeted Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Neoantigen Targeted Therapy Forecast
10.4.2 France Market Neoantigen Targeted Therapy Forecast
10.4.3 UK Market Neoantigen Targeted Therapy Forecast
10.4.4 Italy Market Neoantigen Targeted Therapy Forecast
10.4.5 Russia Market Neoantigen Targeted Therapy Forecast
10.5 Middle East & Africa Neoantigen Targeted Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Neoantigen Targeted Therapy Forecast
10.5.2 South Africa Market Neoantigen Targeted Therapy Forecast
10.5.3 Israel Market Neoantigen Targeted Therapy Forecast
10.5.4 Turkey Market Neoantigen Targeted Therapy Forecast
10.6 Global Neoantigen Targeted Therapy Forecast by Type (2027-2032)
10.7 Global Neoantigen Targeted Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neoantigen Targeted Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 BioNTech SE
11.1.1 BioNTech SE Company Information
11.1.2 BioNTech SE Neoantigen Targeted Therapy Product Offered
11.1.3 BioNTech SE Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BioNTech SE Main Business Overview
11.1.5 BioNTech SE Latest Developments
11.2 Gritstone Bio
11.2.1 Gritstone Bio Company Information
11.2.2 Gritstone Bio Neoantigen Targeted Therapy Product Offered
11.2.3 Gritstone Bio Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gritstone Bio Main Business Overview
11.2.5 Gritstone Bio Latest Developments
11.3 Genocea Biosciences
11.3.1 Genocea Biosciences Company Information
11.3.2 Genocea Biosciences Neoantigen Targeted Therapy Product Offered
11.3.3 Genocea Biosciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Genocea Biosciences Main Business Overview
11.3.5 Genocea Biosciences Latest Developments
11.4 Moderna
11.4.1 Moderna Company Information
11.4.2 Moderna Neoantigen Targeted Therapy Product Offered
11.4.3 Moderna Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Moderna Main Business Overview
11.4.5 Moderna Latest Developments
11.5 Agenus
11.5.1 Agenus Company Information
11.5.2 Agenus Neoantigen Targeted Therapy Product Offered
11.5.3 Agenus Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Agenus Main Business Overview
11.5.5 Agenus Latest Developments
11.6 Immatics
11.6.1 Immatics Company Information
11.6.2 Immatics Neoantigen Targeted Therapy Product Offered
11.6.3 Immatics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Immatics Main Business Overview
11.6.5 Immatics Latest Developments
11.7 Advaxis
11.7.1 Advaxis Company Information
11.7.2 Advaxis Neoantigen Targeted Therapy Product Offered
11.7.3 Advaxis Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Advaxis Main Business Overview
11.7.5 Advaxis Latest Developments
11.8 Precision Biologics
11.8.1 Precision Biologics Company Information
11.8.2 Precision Biologics Neoantigen Targeted Therapy Product Offered
11.8.3 Precision Biologics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Precision Biologics Main Business Overview
11.8.5 Precision Biologics Latest Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Information
11.9.2 Gilead Sciences Neoantigen Targeted Therapy Product Offered
11.9.3 Gilead Sciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Gilead Sciences Main Business Overview
11.9.5 Gilead Sciences Latest Developments
11.10 Cellular Biomedicine Group
11.10.1 Cellular Biomedicine Group Company Information
11.10.2 Cellular Biomedicine Group Neoantigen Targeted Therapy Product Offered
11.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cellular Biomedicine Group Main Business Overview
11.10.5 Cellular Biomedicine Group Latest Developments
11.11 Achilles Therapeutics
11.11.1 Achilles Therapeutics Company Information
11.11.2 Achilles Therapeutics Neoantigen Targeted Therapy Product Offered
11.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Achilles Therapeutics Main Business Overview
11.11.5 Achilles Therapeutics Latest Developments
11.12 Merck and Co
11.12.1 Merck and Co Company Information
11.12.2 Merck and Co Neoantigen Targeted Therapy Product Offered
11.12.3 Merck and Co Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Merck and Co Main Business Overview
11.12.5 Merck and Co Latest Developments
11.13 Beijing Kati Medical Technology
11.13.1 Beijing Kati Medical Technology Company Information
11.13.2 Beijing Kati Medical Technology Neoantigen Targeted Therapy Product Offered
11.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Beijing Kati Medical Technology Main Business Overview
11.13.5 Beijing Kati Medical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neoantigen Targeted Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neoantigen Targeted Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Off-the-shelf Neoantigen
Table 4. Major Players of Personalized Neoantigen
Table 5. Neoantigen Targeted Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Table 8. Neoantigen Targeted Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global Neoantigen Targeted Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Neoantigen Targeted Therapy Revenue Market Share by Player (2021-2026)
Table 13. Neoantigen Targeted Therapy Key Players Head office and Products Offered
Table 14. Neoantigen Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neoantigen Targeted Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Neoantigen Targeted Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global Neoantigen Targeted Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Neoantigen Targeted Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Neoantigen Targeted Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Neoantigen Targeted Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC Neoantigen Targeted Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Neoantigen Targeted Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Neoantigen Targeted Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Neoantigen Targeted Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Neoantigen Targeted Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Neoantigen Targeted Therapy
Table 39. Key Market Challenges & Risks of Neoantigen Targeted Therapy
Table 40. Key Industry Trends of Neoantigen Targeted Therapy
Table 41. Global Neoantigen Targeted Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Neoantigen Targeted Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Neoantigen Targeted Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Neoantigen Targeted Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BioNTech SE Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 46. BioNTech SE Neoantigen Targeted Therapy Product Offered
Table 47. BioNTech SE Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BioNTech SE Main Business
Table 49. BioNTech SE Latest Developments
Table 50. Gritstone Bio Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 51. Gritstone Bio Neoantigen Targeted Therapy Product Offered
Table 52. Gritstone Bio Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Gritstone Bio Main Business
Table 54. Gritstone Bio Latest Developments
Table 55. Genocea Biosciences Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 56. Genocea Biosciences Neoantigen Targeted Therapy Product Offered
Table 57. Genocea Biosciences Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Genocea Biosciences Main Business
Table 59. Genocea Biosciences Latest Developments
Table 60. Moderna Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 61. Moderna Neoantigen Targeted Therapy Product Offered
Table 62. Moderna Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Moderna Main Business
Table 64. Moderna Latest Developments
Table 65. Agenus Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 66. Agenus Neoantigen Targeted Therapy Product Offered
Table 67. Agenus Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Agenus Main Business
Table 69. Agenus Latest Developments
Table 70. Immatics Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 71. Immatics Neoantigen Targeted Therapy Product Offered
Table 72. Immatics Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Immatics Main Business
Table 74. Immatics Latest Developments
Table 75. Advaxis Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 76. Advaxis Neoantigen Targeted Therapy Product Offered
Table 77. Advaxis Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Advaxis Main Business
Table 79. Advaxis Latest Developments
Table 80. Precision Biologics Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 81. Precision Biologics Neoantigen Targeted Therapy Product Offered
Table 82. Precision Biologics Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Precision Biologics Main Business
Table 84. Precision Biologics Latest Developments
Table 85. Gilead Sciences Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 86. Gilead Sciences Neoantigen Targeted Therapy Product Offered
Table 87. Gilead Sciences Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Gilead Sciences Main Business
Table 89. Gilead Sciences Latest Developments
Table 90. Cellular Biomedicine Group Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 91. Cellular Biomedicine Group Neoantigen Targeted Therapy Product Offered
Table 92. Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Cellular Biomedicine Group Main Business
Table 94. Cellular Biomedicine Group Latest Developments
Table 95. Achilles Therapeutics Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 96. Achilles Therapeutics Neoantigen Targeted Therapy Product Offered
Table 97. Achilles Therapeutics Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Achilles Therapeutics Main Business
Table 99. Achilles Therapeutics Latest Developments
Table 100. Merck and Co Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 101. Merck and Co Neoantigen Targeted Therapy Product Offered
Table 102. Merck and Co Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Merck and Co Main Business
Table 104. Merck and Co Latest Developments
Table 105. Beijing Kati Medical Technology Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 106. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product Offered
Table 107. Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Beijing Kati Medical Technology Main Business
Table 109. Beijing Kati Medical Technology Latest Developments
Table 1. Neoantigen Targeted Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neoantigen Targeted Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Off-the-shelf Neoantigen
Table 4. Major Players of Personalized Neoantigen
Table 5. Neoantigen Targeted Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Table 8. Neoantigen Targeted Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global Neoantigen Targeted Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Neoantigen Targeted Therapy Revenue Market Share by Player (2021-2026)
Table 13. Neoantigen Targeted Therapy Key Players Head office and Products Offered
Table 14. Neoantigen Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neoantigen Targeted Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Neoantigen Targeted Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global Neoantigen Targeted Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Neoantigen Targeted Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Neoantigen Targeted Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Neoantigen Targeted Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC Neoantigen Targeted Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Neoantigen Targeted Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Neoantigen Targeted Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Neoantigen Targeted Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Neoantigen Targeted Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Neoantigen Targeted Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Neoantigen Targeted Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Neoantigen Targeted Therapy
Table 39. Key Market Challenges & Risks of Neoantigen Targeted Therapy
Table 40. Key Industry Trends of Neoantigen Targeted Therapy
Table 41. Global Neoantigen Targeted Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Neoantigen Targeted Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Neoantigen Targeted Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Neoantigen Targeted Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BioNTech SE Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 46. BioNTech SE Neoantigen Targeted Therapy Product Offered
Table 47. BioNTech SE Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BioNTech SE Main Business
Table 49. BioNTech SE Latest Developments
Table 50. Gritstone Bio Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 51. Gritstone Bio Neoantigen Targeted Therapy Product Offered
Table 52. Gritstone Bio Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Gritstone Bio Main Business
Table 54. Gritstone Bio Latest Developments
Table 55. Genocea Biosciences Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 56. Genocea Biosciences Neoantigen Targeted Therapy Product Offered
Table 57. Genocea Biosciences Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Genocea Biosciences Main Business
Table 59. Genocea Biosciences Latest Developments
Table 60. Moderna Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 61. Moderna Neoantigen Targeted Therapy Product Offered
Table 62. Moderna Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Moderna Main Business
Table 64. Moderna Latest Developments
Table 65. Agenus Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 66. Agenus Neoantigen Targeted Therapy Product Offered
Table 67. Agenus Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Agenus Main Business
Table 69. Agenus Latest Developments
Table 70. Immatics Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 71. Immatics Neoantigen Targeted Therapy Product Offered
Table 72. Immatics Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Immatics Main Business
Table 74. Immatics Latest Developments
Table 75. Advaxis Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 76. Advaxis Neoantigen Targeted Therapy Product Offered
Table 77. Advaxis Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Advaxis Main Business
Table 79. Advaxis Latest Developments
Table 80. Precision Biologics Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 81. Precision Biologics Neoantigen Targeted Therapy Product Offered
Table 82. Precision Biologics Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Precision Biologics Main Business
Table 84. Precision Biologics Latest Developments
Table 85. Gilead Sciences Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 86. Gilead Sciences Neoantigen Targeted Therapy Product Offered
Table 87. Gilead Sciences Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Gilead Sciences Main Business
Table 89. Gilead Sciences Latest Developments
Table 90. Cellular Biomedicine Group Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 91. Cellular Biomedicine Group Neoantigen Targeted Therapy Product Offered
Table 92. Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Cellular Biomedicine Group Main Business
Table 94. Cellular Biomedicine Group Latest Developments
Table 95. Achilles Therapeutics Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 96. Achilles Therapeutics Neoantigen Targeted Therapy Product Offered
Table 97. Achilles Therapeutics Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Achilles Therapeutics Main Business
Table 99. Achilles Therapeutics Latest Developments
Table 100. Merck and Co Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 101. Merck and Co Neoantigen Targeted Therapy Product Offered
Table 102. Merck and Co Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Merck and Co Main Business
Table 104. Merck and Co Latest Developments
Table 105. Beijing Kati Medical Technology Details, Company Type, Neoantigen Targeted Therapy Area Served and Its Competitors
Table 106. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product Offered
Table 107. Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Beijing Kati Medical Technology Main Business
Table 109. Beijing Kati Medical Technology Latest Developments
LIST OF FIGURES
Figure 1. Neoantigen Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neoantigen Targeted Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neoantigen Targeted Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neoantigen Targeted Therapy Sales Market Share by Country/Region (2025)
Figure 8. Neoantigen Targeted Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neoantigen Targeted Therapy Market Size Market Share by Type in 2025
Figure 10. Neoantigen Targeted Therapy in Colorectal Cancer
Figure 11. Global Neoantigen Targeted Therapy Market: Colorectal Cancer (2021-2026) & ($ millions)
Figure 12. Neoantigen Targeted Therapy in Renal Cell Carcinoma
Figure 13. Global Neoantigen Targeted Therapy Market: Renal Cell Carcinoma (2021-2026) & ($ millions)
Figure 14. Neoantigen Targeted Therapy in Non-Small Cell Lung cancer
Figure 15. Global Neoantigen Targeted Therapy Market: Non-Small Cell Lung cancer (2021-2026) & ($ millions)
Figure 16. Neoantigen Targeted Therapy in Bone Cancer
Figure 17. Global Neoantigen Targeted Therapy Market: Bone Cancer (2021-2026) & ($ millions)
Figure 18. Neoantigen Targeted Therapy in Gynecological Cancer
Figure 19. Global Neoantigen Targeted Therapy Market: Gynecological Cancer (2021-2026) & ($ millions)
Figure 20. Neoantigen Targeted Therapy in Others
Figure 21. Global Neoantigen Targeted Therapy Market: Others (2021-2026) & ($ millions)
Figure 22. Global Neoantigen Targeted Therapy Market Size Market Share by Application in 2025
Figure 23. Global Neoantigen Targeted Therapy Revenue Market Share by Player in 2025
Figure 24. Global Neoantigen Targeted Therapy Market Size Market Share by Region (2021-2026)
Figure 25. Americas Neoantigen Targeted Therapy Market Size 2021-2026 ($ millions)
Figure 26. APAC Neoantigen Targeted Therapy Market Size 2021-2026 ($ millions)
Figure 27. Europe Neoantigen Targeted Therapy Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Neoantigen Targeted Therapy Market Size 2021-2026 ($ millions)
Figure 29. Americas Neoantigen Targeted Therapy Value Market Share by Country in 2025
Figure 30. United States Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Neoantigen Targeted Therapy Market Size Market Share by Region in 2025
Figure 35. APAC Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Figure 36. APAC Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Figure 37. China Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. India Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Neoantigen Targeted Therapy Market Size Market Share by Country in 2025
Figure 44. Europe Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Europe Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Germany Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. France Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Neoantigen Targeted Therapy Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 60. APAC Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 61. Europe Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 63. United States Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 64. Canada Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 65. Mexico Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 66. Brazil Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 67. China Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 68. Japan Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 69. Korea Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 71. India Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 72. Australia Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 73. Germany Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 74. France Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 75. UK Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 76. Italy Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 77. Russia Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 78. Egypt Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 79. South Africa Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 80. Israel Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 81. Turkey Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 82. Global Neoantigen Targeted Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Neoantigen Targeted Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 1. Neoantigen Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neoantigen Targeted Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neoantigen Targeted Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neoantigen Targeted Therapy Sales Market Share by Country/Region (2025)
Figure 8. Neoantigen Targeted Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neoantigen Targeted Therapy Market Size Market Share by Type in 2025
Figure 10. Neoantigen Targeted Therapy in Colorectal Cancer
Figure 11. Global Neoantigen Targeted Therapy Market: Colorectal Cancer (2021-2026) & ($ millions)
Figure 12. Neoantigen Targeted Therapy in Renal Cell Carcinoma
Figure 13. Global Neoantigen Targeted Therapy Market: Renal Cell Carcinoma (2021-2026) & ($ millions)
Figure 14. Neoantigen Targeted Therapy in Non-Small Cell Lung cancer
Figure 15. Global Neoantigen Targeted Therapy Market: Non-Small Cell Lung cancer (2021-2026) & ($ millions)
Figure 16. Neoantigen Targeted Therapy in Bone Cancer
Figure 17. Global Neoantigen Targeted Therapy Market: Bone Cancer (2021-2026) & ($ millions)
Figure 18. Neoantigen Targeted Therapy in Gynecological Cancer
Figure 19. Global Neoantigen Targeted Therapy Market: Gynecological Cancer (2021-2026) & ($ millions)
Figure 20. Neoantigen Targeted Therapy in Others
Figure 21. Global Neoantigen Targeted Therapy Market: Others (2021-2026) & ($ millions)
Figure 22. Global Neoantigen Targeted Therapy Market Size Market Share by Application in 2025
Figure 23. Global Neoantigen Targeted Therapy Revenue Market Share by Player in 2025
Figure 24. Global Neoantigen Targeted Therapy Market Size Market Share by Region (2021-2026)
Figure 25. Americas Neoantigen Targeted Therapy Market Size 2021-2026 ($ millions)
Figure 26. APAC Neoantigen Targeted Therapy Market Size 2021-2026 ($ millions)
Figure 27. Europe Neoantigen Targeted Therapy Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Neoantigen Targeted Therapy Market Size 2021-2026 ($ millions)
Figure 29. Americas Neoantigen Targeted Therapy Value Market Share by Country in 2025
Figure 30. United States Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Neoantigen Targeted Therapy Market Size Market Share by Region in 2025
Figure 35. APAC Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Figure 36. APAC Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Figure 37. China Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. India Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Neoantigen Targeted Therapy Market Size Market Share by Country in 2025
Figure 44. Europe Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Europe Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Germany Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. France Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Neoantigen Targeted Therapy Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Neoantigen Targeted Therapy Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Neoantigen Targeted Therapy Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Neoantigen Targeted Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 60. APAC Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 61. Europe Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 63. United States Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 64. Canada Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 65. Mexico Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 66. Brazil Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 67. China Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 68. Japan Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 69. Korea Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 71. India Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 72. Australia Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 73. Germany Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 74. France Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 75. UK Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 76. Italy Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 77. Russia Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 78. Egypt Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 79. South Africa Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 80. Israel Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 81. Turkey Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
Figure 82. Global Neoantigen Targeted Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Neoantigen Targeted Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Neoantigen Targeted Therapy Market Size 2027-2032 ($ millions)
